Literature DB >> 8582425

Inherited complement deficiency in children surviving fulminant meningococcal septic shock.

H H Derkx1, E J Kuijper, C A Fijen, M Jak, J Dankert, S J van Deventer.   

Abstract

UNLABELLED: We evaluated the complement system in 29 children (mean age: 4.5 years) who survived fulminant meningococcal septic shock. No terminal complement deficiencies were found. One patient, who experienced the most dramatic disease course, had a decreased haemolytic activity in the haemolysis-in-gel test for the alternative pathway. The properdin concentration in serum of this patient was < 0.1 microgram/ml (n = 17.1-27.7 micrograms/ml). Coagulation studies revealed a heterozygeous type I protein C deficiency as well. He was the only patient with a Neisseria meningitidis group Y infection.
CONCLUSION: Fulminant meningococcal disease due to uncommon serogroups should lead to screening of the alternative pathway of complement activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582425     DOI: 10.1007/bf02276718

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections.

Authors:  M Schlesinger; Z Nave; Y Levy; P E Slater; Z Fishelson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Simplified assays of hemolytic activity of the classical and alternative complement pathways.

Authors:  U R Nilsson; B Nilsson
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

Review 3.  Inherited complement deficiency states: implications for immunity and immunological disease.

Authors:  A G Sjöholm
Journal:  APMIS       Date:  1990-10       Impact factor: 3.205

4.  Protein C: comparison of different assays in normal and abnormal plasma samples.

Authors:  H Vinazzer; U Pangraz
Journal:  Thromb Res       Date:  1987-04-01       Impact factor: 3.944

5.  Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987.

Authors:  P L Havens; J S Garland; M M Brook; B A Dewitz; E S Stremski; T J Troshynski
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

6.  Screening for complement deficiencies in unselected patients with meningitis.

Authors:  J M Rasmussen; I Brandslund; B Teisner; H Isager; S E Svehag; L Maarup; L Willumsen; J O Rønne-Rasmussen; H Permin; P L Andersen
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

7.  Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia.

Authors:  E W Gelfand; C P Rao; J O Minta; T Ham; D B Purkall; S Ruddy
Journal:  Am J Med       Date:  1987-03-23       Impact factor: 4.965

8.  Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria.

Authors:  C A Fijen; E J Kuijper; H G Tjia; M R Daha; J Dankert
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

9.  Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.

Authors:  J Andreoni; H Käyhty; P Densen
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

10.  Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.

Authors:  K Fijnvandraat; B Derkx; M Peters; R Bijlmer; A Sturk; M H Prins; S J van Deventer; J W ten Cate
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249

View more
  7 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Investigation for complement deficiency following meningococcal disease.

Authors:  S Hoare; O El-Shazali; J E Clark; A Fay; A J Cant
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.

Authors:  Dan M Granoff
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

Review 5.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

Review 6.  The role of complement system in septic shock.

Authors:  Jean Charchaflieh; Jiandong Wei; Georges Labaze; Yunfang Joan Hou; Benjamin Babarsh; Helen Stutz; Haekyung Lee; Samrat Worah; Ming Zhang
Journal:  Clin Dev Immunol       Date:  2012-09-23

Review 7.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.